Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP - PubMed (original) (raw)
Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP
J S Schneider et al. Brain Res. 1987.
Abstract
Tyrosine hydroxylase immunohistochemical examination of the mesencephalon of severely parkinsonian MPTP-treated macaque fascicularis monkeys revealed a marked loss of substantia nigra pars compacta (SNc) neurons in both medial and central portions of the nucleus with a relative sparing of neurons in the dorsal-most portions of the substantia nigra. These animals also sustained 20-65% loss of neurons in the substantia nigra pars lateralis area, ventral tegmental area (A-10), and the retrorubral area (A-8 cell group, and the parabrachialis pigmentosus region). These animals all had extreme striatal dopamine depletions. A monkey which received several small doses of MPTP and yet remained asymptomatic for a motor disorder (although it had demonstrable behavioral performance deficits) had only a loss of ventral SNc neurons, with no appreciable cell loss in associated ventral mesencephalic dopamine areas and no loss of striatal dopamine. These data suggest that the effects of MPTP are not as selective as originally thought and, more importantly, indicate that MPTP-induced parkinsonism in the primate may be more analogous to idiopathic Parkinson's disease, where cells other than SNc cells are affected. Furthermore, the present findings suggest that only certain mesencephalic dopamine neurons are susceptible to MPTP-induced damage. The unique characteristics of these neurons need to be elucidated.
Similar articles
- MPTP-induced ventral mesencephalic cell loss in the cat.
Williams JL, Schneider JS. Williams JL, et al. Neurosci Lett. 1989 Jul 3;101(3):258-62. doi: 10.1016/0304-3940(89)90542-9. Neurosci Lett. 1989. PMID: 2570385 - Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus.
Mitchell IJ, Cross AJ, Sambrook MA, Crossman AR. Mitchell IJ, et al. Neurosci Lett. 1985 Oct 24;61(1-2):195-200. doi: 10.1016/0304-3940(85)90424-0. Neurosci Lett. 1985. PMID: 3878482 - 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost?
German DC, Dubach M, Askari S, Speciale SG, Bowden DM. German DC, et al. Neuroscience. 1988 Jan;24(1):161-74. doi: 10.1016/0306-4522(88)90320-x. Neuroscience. 1988. PMID: 3259295 - The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
Jenner P, Marsden CD. Jenner P, et al. J Neural Transm Suppl. 1986;20:11-39. J Neural Transm Suppl. 1986. PMID: 3091760 Review. - MPTP-induced parkinsonism in the monkey: neurochemical pathology, complications of treatment and pathophysiological mechanisms.
Crossman AR, Clarke CE, Boyce S, Robertson RG, Sambrook MA. Crossman AR, et al. Can J Neurol Sci. 1987 Aug;14(3 Suppl):428-35. doi: 10.1017/s0317167100037859. Can J Neurol Sci. 1987. PMID: 3119180 Review.
Cited by
- Neuron-selective changes in RNA transcripts related to energy metabolism in toxic models of parkinsonism in rodents.
Greene JG, Dingledine R, Greenamyre JT. Greene JG, et al. Neurobiol Dis. 2010 Jun;38(3):476-81. doi: 10.1016/j.nbd.2010.03.014. Epub 2010 Mar 20. Neurobiol Dis. 2010. PMID: 20307667 Free PMC article. - Corticotropin-releasing factor binding protein within the ventral tegmental area is expressed in a subset of dopaminergic neurons.
Wang HL, Morales M. Wang HL, et al. J Comp Neurol. 2008 Jul 20;509(3):302-18. doi: 10.1002/cne.21751. J Comp Neurol. 2008. PMID: 18478589 Free PMC article. - Short and long-term changes in cerebral [14C]-2-deoxyglucose uptake in the MPTP-treated marmoset: relationship to locomotor activity.
Gnanalingham KK, Milkowski NA, Smith LA, Hunter AJ, Jenner P, Marsden CD. Gnanalingham KK, et al. J Neural Transm Gen Sect. 1995;101(1-3):65-82. doi: 10.1007/BF01271546. J Neural Transm Gen Sect. 1995. PMID: 8695058 - The medial and lateral substantia nigra in Parkinson's disease: mRNA profiles associated with higher brain tissue vulnerability.
Duke DC, Moran LB, Pearce RK, Graeber MB. Duke DC, et al. Neurogenetics. 2007 Apr;8(2):83-94. doi: 10.1007/s10048-006-0077-6. Epub 2007 Jan 9. Neurogenetics. 2007. PMID: 17211632 - Glutamate homeostasis and dopamine signaling: Implications for psychostimulant addiction behavior.
Fischer KD, Knackstedt LA, Rosenberg PA. Fischer KD, et al. Neurochem Int. 2021 Mar;144:104896. doi: 10.1016/j.neuint.2020.104896. Epub 2020 Nov 5. Neurochem Int. 2021. PMID: 33159978 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous